First-Line Nivolumab Shows Promise in Early-Stage, Unfavorable Hodgkin Lymphoma
Researchers sought to determine whether combining nivolumab with chemotherapy and radiotherapy would be effective in early-stage, unfavorable Hodgkin lymphoma.
Researchers sought to determine whether combining nivolumab with chemotherapy and radiotherapy would be effective in early-stage, unfavorable Hodgkin lymphoma.
Researchers sought to determine whether the short-term CARMEN would be effective in HIV-positive patients with MYC-rearranged aggressive lymphoma.
Researchers sought to determine whether MRI could show evidence of brain infarction in patients with iTTP.
Researchers sought to determine whether combining imatinib with ISR inhibition would improve leukemic cell eradication in CML.
Researchers sought to determine whether there were racial disparities in care for patients with SCD.
Researchers sought to determine whether combining pozelimab and cemdisiran would be an effective treatment for patients with PNH.
Researchers sought to determine whether treatment with betibeglogene autotemcel could improve QoL in patients with transfusion-dependent beta-thalassemia.
Researchers sought to determine whether the EASIX score could predict NRM in patients with hematologic cancer who undergo haplo-SCT with cyclophosphamide.
Early results appear promising for frontline asciminib in patients with chronic phase chronic myeloid leukemia, according to researchers.
Researchers sought to determine whether immune checkpoint inhibitors would increase risk of VTE compared with chemotherapy among patients with cancer.